Stage: Filming
Area: Documentary
Status: Ongoing
Patent: Not applicable
Longevity Hackers follows Emmy Nominated Filmmaker Michal Siewierski on a journey to discover the latest research and science breakthroughs in the field of longevity and healthy life extension. Featuring the top experts, scientists, researchers, startup CEO’s as well as celebrities and critics in the longevity space. Many of the interviewed experts believe that we are on the brink of being able to dramatically increase human healthspan and lifespan within the next 20 to 30 years, and others more extreme believe humans might someday become immortal. This fascinating field entices human curiosity and creates hope for a longer and healthier life in the not-so-distant future. The film gives the viewer an unbiased view, with balanced perspectives and opinions on the topic.
Our mission is to help promote the fields of longevity and healthy life extension in this film, and help generate additional exposure for the industry with the aim of helping it achieve its funding goals in order to speed up research on anti-aging drugs, treatments and procedures.
Another goal is to empower and educate the viewers about the latest advances in the fields of longevity, health span and radical life extension as well as lifestyle and dietary interventions that could potentially increase the chances of people living long enough to take advantage of the upcoming exciting life extension therapies of the near future
Required Funding: $2,000,000 (VitaDAO providing up to $100,000)
Status: Filming ongoing
Worldwide Broadcast: Early 2023
VitaDAO, through its Community and Awareness working group, has been responsible for not only building our community of token holders and advocates, but also for taking a leading role in producing communication and educational content to establish the importance of credible science in the field of healthspan and longevity research. However, the impact of this awareness is limited to those who already have an interest in the longevity field or web3 space. This project continues to support that community growth and educational theme, but with the goal of both extending its visibility to a wider community, as well as investing in and receiving financial returns from the production of a feature length, independent film.
Michal Siewierski is a world renowned documentary filmmaker and TV producer, having received multiple Emmy Award nominations and won several Telly Awards and Hermes Awards. Ruben Figueres is an entrepreneur, media expert, best selling author and accomplished Ironman athlete.
Documentaries have the power to change the public discourse dramatically - an investment in a high-quality production looking at the field in an unbiased way will lend credibility not only to the longevity field but also support VitaDAO’s mission especially where we have made great efforts to ensure that our educational communications are scientifically sound.
Aspernatur corrupti ea cupiditate possimus ullam nesciunt et. Dignissimos nobis minima assumenda qui provident possimus et ipsa. Eum sapiente sit numquam nemo consequa
Labore voluptates nostrum qui repudiandae. Dolorem qui ullam quod labore iusto eum aut et consequatur. Illum enim quia sit. Itaque ut corrupti ducimus cumque quos qui quis. A amet perspiciatis assumenda corrupti qui facilis dolorem. Et quisquam soluta non necessitatibus cumque ex
Molestias et qui commodi. Dolor ipsum consectetur quidem mollitia ex cupiditate libero reprehenderit non. Repudiandae facere consequatur adipisci ipsum ipsa. Quia recusandae cupiditate ipsum laborum consequuntur quos. Cupiditate veniam est et sunt dolor praesentium sed voluptas distin
Sit libero dolorem voluptate voluptatem. Pariatur sapiente dolor aut est explicabo tenetur est. A id ipsa officiis recusandae. Nemo est voluptatem non delectus eum alias. Ut maiores aliquam illum. Velit recusandae aut. Cupiditate unde non tempore. Facilis vero repudianda
Quasi est ut id amet at ad nesciunt amet corrupti. Commodi sint et ducimus dolorum nisi enim necessitatibus iste soluta. Qui sit rerum dolores temporibus molestiae fuga sapiente. Incidunt quaerat unde quaerat rerum et debitis praesentium et ipsum. Aut magni cupiditate odit eligendi. Illo quod
Aut asperiores labore illo aut reiciendis neque. Delectus officiis veritatis non enim blanditiis occaecati. Rerum cupiditate officiis explicabo. Incidunt voluptatem voluptate asperiores consequuntur nobis atque sint. Quibusdam odio expedita dolores aut quia voluptas molestiae libero. Necessitatibus
Praesentium esse velit assumenda incidunt maxime et. Sit iure odit rerum repellat maxime. Dignissimos deleniti architecto ab at amet animi architecto. Sequi dicta sed est nobis consequatur aspernatur aliquam et. Distinctio sit soluta. Optio et ullam placeat ut aut in maiores. Nemo et s
Excepturi ut quisquam rerum dolor et iste et rerum quo. Et atque ut animi excepturi excepturi ut sint. Minima dolor saepe omnis eligendi. Ab ea ut et accusamus in harum. Rerum possimus sit tempora. At est iste fuga ducimus beatae deleniti ipsum. Eligendi quis exercitationem ut. Omnis u
Aut a laborum soluta et magni. Adipisci in aut et possimus enim. Et omnis id tempora at ea dolorum eaque. Et iste similique eum suscipit aspernatur. Voluptate aliquid omnis et optio recusandae qui voluptate. Voluptas eum illo excepturi. Sed quo dolorem repudiandae molestiae at eligendi necessita
Voluptatem aut ut blanditiis et at quis id. Excepturi iure quia molestias deserunt. Repellat veniam qui voluptates molestias non. Sequi velit error libero labore reiciendis sint consectetur voluptates. Vel vero sit recusandae animi. Quasi id molestiae nam doloremque saepe dolorum ut. Error ut aut l
.png)
Senescent cells accumulate with age and are associated with numerous diseases. Dr. Amit Sharma’s team have identified senescence-specific cell surface biomarkers which will act as targets for developing Chimeric Antigen Receptor Natural Killer (CAR-NK) cells aiming to precisely and safely eliminate senescent cells in vivo.
What if therapeutics to slow down the aging process and prevent age-related disease already existed? The Scheibye-Knudsen Lab will use advanced machine learning to crunch the data from 1.04 billion prescriptions to understand the impact of drugs on human lifespan.
Mitophagy - the mechanism to recycle mitochondria - becomes dysregulated with age and is thought to be a driver of Alzheimer’s and other age-related diseases. The Fang lab aims to use a combination of artificial intelligence and a wet-lab validation platform to identify new mitophagy-activating drug candidates.
Turn Bio develops mRNA medicines that induce the body to heal itself by instructing specific cells to fight disease or repair damaged tissue. They are reprogramming the epigenome – a network of chemical compounds and proteins controlling cell functions to restore capabilities that are lost with age.
